Tamta Melashvili

Person · Open Library

Works

1

via Open Library + Wikidata

Academic profile · OpenAlex

Works

1

Cited by

0

via OpenAlex · CC0

Recent publications · Crossref

5 total works indexed

1. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

   · 2021 · cited 688x

2. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

   · 2022 · cited 479x